PW Medtech Group Limited
HKSE 1358.HK
PW Medtech Group Limited Price to Book Ratio (P/B) on January 14, 2025: 0.31
PW Medtech Group Limited Price to Book Ratio (P/B) is 0.31 on January 14, 2025, a 12.24% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
-
PW Medtech Group Limited 52-week high Price to Book Ratio (P/B) is 0.41 on July 29, 2024, which is 30.11% above the current Price to Book Ratio (P/B).
-
PW Medtech Group Limited 52-week low Price to Book Ratio (P/B) is 0.25 on January 31, 2024, which is -20.50% below the current Price to Book Ratio (P/B).
-
PW Medtech Group Limited average Price to Book Ratio (P/B) for the last 52 weeks is 0.34.
Key data
| Date | Price to Book Ratio (P/B) | Dividend Yield | Free Cash Flow Yield | Price to Earnings Ratio (P/E) |
|---|
Market news
Loading...
HKSE: 1358.HK
| CEO | Ms. Yue'e Zhang |
| IPO Date | Nov. 8, 2013 |
| Location | China |
| Headquarters | Building 1 |
| Employees | 1,302 |
| Sector | Health Care |
| Industries | |
Description
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People's Republic of China. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens. It also provides property management services. The company was formerly known as Pyholding Limited. PW Medtech Group Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Key trends
Past 5 years
Similar companies
China Pioneer Pharma Holdings Limited
USD 0.30
-0.02%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
USD 0.29
2.68%
StockViz Staff
January 15, 2025
Any question? Send us an email